Publish with CMH
- Page Path
-
- HOME
- FOR CONTRIBUTORS
- Publish with CMH
We always support the authors who trust us to publish their research.
CMH has the following characteristics:
▶ Open Access. Everyone everywhere can read your research without cost.
▶ Easy and convenient online submission management system
▶ Quick, fair, transparent decision
▶ Broad readership
▶ No page charge for publication
▶ Rapid publication online first ahead of print and “Ahead-of-print” uploads
▶ Prompt report of new developments and significant applications in the analytical technology and equipment
We welcome you to submit your manuscript now and join our authors who have published with Clinical and Molecular Hepatology.
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Immunopathogenesis of liver fibrosis in steatotic liver disease
- Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
- Recent updates on pharmacologic therapy in non-alcoholic fatty liver disease
- The role of the hepatic autonomic nervous system
- HBeAg-positive grey-zone patients: Treatment beyond guideline recommendations?
- Systemic therapy in advanced hepatocellular carcinoma
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
Impact Factor14.0First decision
07 Days
Publication after acceptance
03 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2022-2024)
|
|||||||
